uniQure QURE Return on equity

Return on equity at other companies

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

Taysha Gene Therapies, Inc.TSHA

-97.3%-27.3pp

Design Therapeutics, Inc.DSGN

-31.3%+19.5pp

Candel Therapeutics, Inc.CADL

-51.2%-16.6pp

RegenxbioRGNX

-137.6%-817pp

Opus GeneticsIRD

-449.4%-2,573pp

FAQ

What is uniQure's return on equity?

uniQure (QURE) reported return on equity of -228.2% in Q1 2026.

How has uniQure's return on equity changed year-over-year?

uniQure's return on equity increased by 5.4% year-over-year, from -241.2% to -228.2%.

What is the long-term trend for uniQure's return on equity?

Over 3 years (2020 to 2023), uniQure's return on equity has grown at a 27.0% compound annual growth rate (CAGR), from -44.1% to -90.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.